Atlas Trials

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Clinical trial NCT07455903 · RECRUITING

Trial details

NCT number
NCT07455903
Sponsor
Baptist Health South Florida
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerLocalized Prostate Carcinoma
Start date
2026-07-29
Primary completion
2030-02-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.